KLF5 and prostate carcinoma: Consistently, knockdown of KLF5 in PTEN-insufficient human prostate cancer cells increased tube formation and migration in HuVECs, enhanced PI3K/AKT activity, and upregulated HIF1α, VEGF and PDGF.